Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-1101 in Patients Scheduled for Multi-Slice CT
NCT00924586Phase 3Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of landiolol in coronary artery disease (CAD), sponsored by Ono Pharmaceutical. Started Jun 2009; status: completed.
02
Drugs
landiolol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00924586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924586.